Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Lung Cancer (Stage III)”

1,858 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,858 results

Not applicableStudy completedNCT02629458
What this trial is testing

Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection

Who this might be right for
Oncology
The Leeds Teaching Hospitals NHS Trust 54
Large-scale testing (Phase 3)Study completedNCT02813785
What this trial is testing

Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 565
Testing effectiveness (Phase 2)Ended earlyNCT01857271
What this trial is testing

Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer
Albert Einstein College of Medicine 3
Testing effectiveness (Phase 2)Study completedNCT04245085
What this trial is testing

ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma

Who this might be right for
EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
ETOP IBCSG Partners Foundation 95
Large-scale testing (Phase 3)Active Not RecruitingNCT04380636
What this trial is testing

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 870
Not applicableStudy completedNCT00960271
What this trial is testing

Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
University Hospital, Rouen 363
Testing effectiveness (Phase 2)Study completedNCT00004238
What this trial is testing

10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00951444
What this trial is testing

Gemcitabine Hydrochloride and Carboplatin With or Without MK-0646 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00867009
What this trial is testing

Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Eli Lilly and Company 113
Testing effectiveness (Phase 2)UnknownNCT00033722
What this trial is testing

Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Tularik
Testing effectiveness (Phase 2)Study completedNCT00003231
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Swiss Cancer Institute 40
Large-scale testing (Phase 3)Active Not RecruitingNCT02595944
What this trial is testing

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

Who this might be right for
Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage II Lung Non-Small Cell Cancer AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 903
Large-scale testing (Phase 3)UnknownNCT00268684
What this trial is testing

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell LungNeoplasm Metastasis
Tel-Aviv Sourasky Medical Center 381
Early research (Phase 1)Study completedNCT00032032
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 69
Testing effectiveness (Phase 2)Study completedNCT00564733
What this trial is testing

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

Who this might be right for
Malignant Pleural EffusionStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
University of Washington 55
Large-scale testing (Phase 3)Ended earlyNCT00858364
What this trial is testing

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemiaCancer+1 more
Amgen 2,549
Large-scale testing (Phase 3)Study completedNCT01631136
What this trial is testing

Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer

Who this might be right for
Advanced Non Small Cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 932
Large-scale testing (Phase 3)Not Yet RecruitingNCT06335355
What this trial is testing

A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd 401
Testing effectiveness (Phase 2)Study completedNCT00280735
What this trial is testing

Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 75
Large-scale testing (Phase 3)Active Not RecruitingNCT03789604
What this trial is testing

CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
CStone Pharmaceuticals 479
Load More Results